Search

everythinglearnresearchcommunity

for

Search:↓

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

No cure for female pattern hair loss, but various effective treatments exist.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Certain signals and genes play a key role in hair growth and regeneration, and understanding these could lead to new treatments for skin regeneration.

RANK-RANKL signaling is essential for hair growth and skin health.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

MicroRNAs are crucial for controlling skin development and healing by regulating genes.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Mutations in the LSS gene cause a rare type of hereditary hair loss.

Activating β-catenin in different skin stem cells causes various types of hair growth and skin tumors.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

UVB radiation harms hair growth and health, causing cell death and other changes in human hair follicles.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

miR-22, a type of microRNA, controls hair growth and its overproduction can cause hair loss, while its absence can speed up hair growth.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.